Suspected of kickback! 14 pharmaceutical centralized purchase platforms suspended

[industry trends of pharmaceutical network] on August 26, Hunan Public Resources Trading Center issued the notice on suspending the qualification of some enterprises involved in drug network (hereinafter referred to as the notice) According to the notice on the treatment of typical cases involving enterprises in the recent unhealthy trend of the health industry in Hunan Province issued by Hunan Medical Insurance Bureau, 14 drugs were suspended from the qualification of hanging the network of the provincial medicine centralized purchase platform from August 26, according to the notice Among these 14 varieties, there are some well-known ones The main reason for the suspension of the qualification of these 14 varieties is that these drug manufacturers are suspected of kickbacks In fact, in recent years, the anti-corruption storm in Hunan Province is more and more fierce As early as 2018, at the contact meeting of Hunan provincial departments to correct the unhealthy trend in the field of medicine purchase and sale and medical services, it was emphasized to clean up, investigate and punish, crack down on the illegal behaviors such as fraud and deception of medical insurance funds, "intraoperative price increase" and medical personnel's hospital promotion of medical supplies, so as to promote the formation of a clean and healthy health industry in Hunan Province On July 31 this year, Xiangya Hospital held a total of 425 collective incorruption meetings with business contacts, aiming to strengthen the construction of style in the medical and health industry and the governance of unhealthy practices in medical services At the meeting, a typical case of the recent unhealthy trend in the health industry of Hunan Province was reported At the same time, it is emphasized that the hospital will adhere to the principle of no forbidden zone, full coverage and zero tolerance, and will never condone and show no mercy to the problems of integrity and corruption in business dealings Once it is found that there is a violation of the provisions of the integrity contract, the hospital will immediately terminate the purchase and sale contract, list the company in the record of bad behavior, and cancel all cooperation qualifications with the hospital In addition to Hunan, Jiangsu, Anhui and other places have also carried out anti-corruption work in public hospitals And in 2019, the horn of the national health system anti-corruption war continues to blow   At the beginning of August this year, the national health and Health Commission, the National Health Insurance Bureau and other nine departments jointly issued the notice on printing and distributing the key points of rectifying the unhealthy trend in the field of medicine purchase and sale and medical service in 2019, which requires strictly regulating the academic conferences, scientific research cooperation, academic support, donation and financing among the Medical Association (school), medical institutions, medical personnel and pharmaceutical related enterprises, and strictly Punish the supply and marketing chain for illegal crimes At the same time, it is emphasized to establish and improve the working mechanism among mechanism members Establish the mechanism of case clue notification and coordination, and carry out "multiple investigations for one case" We will improve the "blacklist" system of joint punishment for wind rectification, and achieve "one violation and restriction everywhere" In addition, the State Administration of market also issued a notice to clarify that anti unfair competition law enforcement actions in key areas will be carried out nationwide from August to December, and the national market regulatory authorities will be organized to carry out this special law enforcement action Commercial bribery in the field of medicine is one of the key areas At the same time, it is required to investigate and deal with a number of unfair competition cases with typical significance, which seriously affect the order of competition and infringe on the legitimate rights and interests of business operators and consumers According to incomplete statistics in the industry, in 2019, there have been more than 10 incidents involving the death of the hospital president alone, involving Chongqing, Jiangsu, Guangxi and other places, and the amount of bribes taken by the president involved in the case is more than 11 million In general, with the continuous promotion of the relevant national anti-corruption work and the constant exposure of the incident, it is conducive to the rectification of the industry Drug companies are facing increasing pressure on sales, and only compliance management is the long-term way.